These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 15208908

  • 1. [From fibrinogen and hirudin to synthetic anticoagulants. Rational design of thrombin inhibitors].
    Steinmetzer T, Stürzebecher J.
    Pharm Unserer Zeit; 2004; 33(3):196-205. PubMed ID: 15208908
    [No Abstract] [Full Text] [Related]

  • 2. Direct thrombin inhibitors.
    Maffrand JP.
    Nouv Rev Fr Hematol (1978); 1992; 34(6):405-19. PubMed ID: 1300540
    [Abstract] [Full Text] [Related]

  • 3. From natural to synthetic multisite thrombin inhibitors.
    Lombardi A, De Simone G, Galdiero S, Staiano N, Nastri F, Pavone V.
    Biopolymers; 1999; 51(1):19-39. PubMed ID: 10380350
    [Abstract] [Full Text] [Related]

  • 4. A screening procedure to evaluate the anticoagulant activity and the kinetic behaviour of direct thrombin inhibitors.
    Rupin A, Mennecier P, de Nanteuil G, Laubie M, Verbeuren TJ.
    Thromb Res; 1995 May 01; 78(3):217-25. PubMed ID: 7631302
    [Abstract] [Full Text] [Related]

  • 5. [Hirudin and other thrombin inhibitors from blood-sucking animals].
    Landmann H.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972 May 01; 98(4):437-45. PubMed ID: 4121337
    [No Abstract] [Full Text] [Related]

  • 6. Low plasma fibrinogen levels with the Clauss method during anticoagulation with bivalirudin.
    Molinaro RJ, Szlam F, Levy JH, Fantz CR, Tanaka KA.
    Anesthesiology; 2008 Jul 01; 109(1):160-1. PubMed ID: 18580197
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the anticoagulant activities of thrombin inhibitors as assessed by thromboelastographic analysis.
    Callas D, Iqbal O, Fareed J.
    Semin Thromb Hemost; 1995 Jul 01; 21 Suppl 4():76-9. PubMed ID: 8747693
    [No Abstract] [Full Text] [Related]

  • 8. Effects of hirudin (thrombin specific inhibitor) in zebrafish embryos: a developmental role for thrombin.
    Jagadeeswaran P, Liu YC, Eddy CA.
    Blood Cells Mol Dis; 1997 Dec 01; 23(3):410-4. PubMed ID: 9446755
    [Abstract] [Full Text] [Related]

  • 9. Synthetic low-molecular weight thrombin inhibitors: the ideal antithrombotic drug? An introduction.
    Stürzebecher J, Meier J.
    J Enzyme Inhib; 1995 Dec 01; 9(1):1-2. PubMed ID: 8568561
    [No Abstract] [Full Text] [Related]

  • 10. Identification of glycyrrhizin as a thrombin inhibitor.
    Francischetti IM, Monteiro RQ, Guimarães JA.
    Biochem Biophys Res Commun; 1997 Jun 09; 235(1):259-63. PubMed ID: 9196073
    [Abstract] [Full Text] [Related]

  • 11. [Stabilization of donor blood with thrombin inhibitors].
    Drawert J, Stein P.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Jun 09; 113(4):560-5. PubMed ID: 2431979
    [Abstract] [Full Text] [Related]

  • 12. Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles.
    Isaacs RC, Solinsky MG, Cutrona KJ, Newton CL, Naylor-Olsen AM, McMasters DR, Krueger JA, Lewis SD, Lucas BJ, Kuo LC, Yan Y, Lynch JJ, Lyle EA.
    Bioorg Med Chem Lett; 2008 Mar 15; 18(6):2062-6. PubMed ID: 18291642
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis and antithrombin activity for conformationally restricted analogs of peptide anticoagulants based on the C-terminal region of the leech peptide, hirudin.
    Krstenansky JL, Owen TJ, Yates MT, Mao SJ.
    Biochim Biophys Acta; 1988 Nov 02; 957(1):53-9. PubMed ID: 3179320
    [Abstract] [Full Text] [Related]

  • 14. Pharmacology and therapeutic applications of hirudin, a new anticoagulant.
    Glusa E.
    Kidney Int Suppl; 1998 Feb 02; 64():S54-6. PubMed ID: 9475490
    [No Abstract] [Full Text] [Related]

  • 15. Phenolic P2/P3 core motif as thrombin inhibitors--design, synthesis, and X-ray co-crystal structure.
    Hanessian S, Therrien E, van Otterlo WA, Bayrakdarian M, Nilsson I, Fjellström O, Xue Y.
    Bioorg Med Chem Lett; 2006 Feb 15; 16(4):1032-6. PubMed ID: 16290930
    [Abstract] [Full Text] [Related]

  • 16. Thrombin active site inhibitors.
    Das J, Kimball SD.
    Bioorg Med Chem; 1995 Aug 15; 3(8):999-1007. PubMed ID: 7582987
    [Abstract] [Full Text] [Related]

  • 17. Synthetic direct thrombin inhibitors in unstable angina - more questions than answers.
    Oberhoff M, Karsch KR.
    Eur Heart J; 1999 Aug 15; 20(15):1058-60. PubMed ID: 10413631
    [No Abstract] [Full Text] [Related]

  • 18. The effect of hirudin on antagonisting thrombin induced apoptosis of human microvascular endothelial cells1.
    Zhu J, Pan X, Lin B, Lin G, Pradhan R, Long F, Yin G.
    Acta Cir Bras; 2019 Feb 14; 34(1):e20190010000006. PubMed ID: 30785507
    [Abstract] [Full Text] [Related]

  • 19. [On the biochemistry of thrombins].
    Walsmann P, Markwardt F.
    Pharmazie; 1968 Nov 14; 23(11):597-608. PubMed ID: 4887336
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacologic aspects of the development of selective synthetic thrombin inhibitors as anticoagulants.
    Hauptmann J, Markwardt F.
    Semin Thromb Hemost; 1992 Nov 14; 18(2):200-17. PubMed ID: 1631568
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.